TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
EW

Edwards Lifesciences Corp

Healthcare · Medical Devices

85.80$ -0.8% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Income Statement

Edwards Lifesciences Corp (EW) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,741 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size % Per share
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement EW
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
739 768 884 842 822 889 895 944 907 978 993 1,087 1,094 1,174 1,129 925 1,141 1,192 1,217 1,376 1,310 1,330 1,341 1,374 1,319 1,348 1,460 1,296 1,243 1,266 1,330 1,386 1,354 1,386 1,413 1,532 1,553 1,570 1,649 1,741 6,512
198 210 218 209 216 235 232 234 220 236 239 315 305 295 271 246 287 295 288 326 301 311 307 286 281 296 359 271 272 251 289 298 263 292 302 343 345 341 359 391 1,436
541 557 665 633 605 653 663 710 686 742 754 772 789 879 858 679 854 897 929 1,050 1,009 1,019 1,035 1,088 1,038 1,053 1,100 1,025 971 1,015 1,041 1,088 1,092 1,094 1,111 1,190 1,210 1,229 1,289 1,350 5,078
113 115 129 134 143 147 143 154 162 163 171 192 196 194 187 182 196 196 207 225 238 233 229 251 234 232 261 244 243 242 257 273 253 271 255 276 281 268 263 279 1,091
230 234 230 244 245 267 256 275 270 288 280 309 306 347 308 275 307 308 326 375 364 424 370 388 377 411 437 469 440 479 490 451 421 492 466 502 515 603 522 561 2,201
343 349 358 378 387 412 398 428 431 451 452 501 502 542 496 458 503 534 538 599 602 657 599 660 611 643 698 654 625 659 685 723 741 781 716 759 785 859 775 831 3,249
199 209 308 255 218 241 265 282 255 290 302 271 287 337 362 221 351 362 391 451 407 362 436 428 427 410 403 371 347 357 356 365 351 313 395 431 425 370 515 520 1,830
2.1 8.6 2.5 1.5 0.1 1.0 0.8 0.2 2.1 1.8 2.0 2.4 2.8 28 4.5 1.8 0.8 1.0 1.3 2.5 2.4 1.2 1.0 1.1 6.9 7.9 10 9.1 – 28 – – – – – – – – – – –
185 200 294 206 212 324 264 251 249 -1.8 278 271 302 316 365 -168 364 356 389 546 391 376 436 465 407 459 399 275 388 367 371 387 403 390 434 400 348 90 459 520 1,418
44 42 63 20 42 327 57 -32 23 -8.8 28 29 27 35 54 -46 39 47 51 56 51 41 63 58 64 61 58 21 53 34 46 20 41 45 70 64 56 26 78 278 439
141 159 230 186 170 36 207 283 226 7.0 250 242 275 280 311 -122 325 310 338 490 340 335 374 406 344 398 341 307 385 370 352 364 3,071 386 358 330 291 91 381 242 1,005
203 228 317 226 233 343 283 270 270 18 304 299 332 346 396 -137 398 397 430 591 434 418 479 507 449 501 441 311 425 404 410 426 429 484 471 400 388 133 500 562 1,583

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?